302 related articles for article (PubMed ID: 34937)
1. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
Giebink GS; Grebner JV; Kim Y; Quie PG
Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
[TBL] [Abstract][Full Text] [Related]
2. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
3. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
[TBL] [Abstract][Full Text] [Related]
4. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
6. Opsonic activity of immunoglobulin prepared for intravenous use.
Hetherington SV; Giebink GS
J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
[TBL] [Abstract][Full Text] [Related]
7. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
Giebink GS; Foker JE; Kim Y; Schiffman G
J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
[No Abstract] [Full Text] [Related]
9. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
[TBL] [Abstract][Full Text] [Related]
10. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
Takahashi H; Oishi K; Yoshimine H; Kumatori A; Moji K; Watanabe K; Nalwoga H; Tugume SB; Kebba A; Mugerwa R; Mugyenyi P; Nagatake T
Clin Infect Dis; 2003 Dec; 37(11):1534-40. PubMed ID: 14614677
[TBL] [Abstract][Full Text] [Related]
12. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
[TBL] [Abstract][Full Text] [Related]
13. Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
McNeely T; Luo S; Manger W; Herber W; Schofield T; Tan C; Newman K; Sadoff J; Donnelly J; Cross A
Vaccine; 2006 Mar; 24(11):1941-8. PubMed ID: 16307833
[TBL] [Abstract][Full Text] [Related]
14. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.
Musher DM; Phan HM; Watson DA; Baughn RE
J Infect Dis; 2000 Jul; 182(1):158-67. PubMed ID: 10882593
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
Bjornson AB; Lobel JS
J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
[TBL] [Abstract][Full Text] [Related]
16. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
Giebink GS; Verhoef J; Peterson PK; Quie PG
Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
[TBL] [Abstract][Full Text] [Related]
17. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
Bjornson AB; Lobel JS; Harr KS
J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
[TBL] [Abstract][Full Text] [Related]
18. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
[TBL] [Abstract][Full Text] [Related]
19. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
